520 studies found for:    "Visceral steatosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Fatty Acids, Genes and Microbiota in Fatty Liver
Conditions: Nonalcoholic Fatty Liver Disease;   Steatosis;   Nonalcoholic Steatohepatitis
Intervention:
2 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
Intervention:
3 Completed Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Conditions: Fatty Liver;   Nonalcoholic Steatohepatitis
Intervention: Drug: Pioglitazone
4 Completed Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Steatohepatitis
Intervention: Drug: Spironolactone/Vitamin E
5 Unknown  An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
Conditions: Psoriasis Chronic;   Liver Fibrosis;   Fatty Liver;   Non-alcoholic Fatty Liver Disease
Intervention: Device: Transient elastography
6 Recruiting Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
Conditions: Fatty Liver;   Hepatic Steatosis;   Liver Steatosis
Interventions: Device: FibroTouch;   Procedure: Liver Biopsy
7 Recruiting Fatty Liver Disease Collaborative Research in China
Conditions: Fatty Liver;   Fatty Liver, Alcoholic;   Non-alcoholic Fatty Liver Disease
Intervention:
8 Completed Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients
Conditions: Fatty Liver;   Steatohepatitis
Intervention: Drug: Rifaximin
9 Unknown  Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease in Diabetic Patients
Conditions: Nonalcoholic Fatty Liver Disease (NAFLD).;   Nonalcoholic Steatohepatitis.;   Diabetes.
Interventions: Procedure: Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).;   Other: Low carbohydrate diet
10 Unknown  Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: metformin;   Drug: losartan
11 Active, not recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
12 Terminated
Has Results
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
Conditions: HIV;   Hepatitis C;   Liver Disease;   Fatty Liver;   Steatosis
Intervention: Drug: Pioglitazone
13 Completed Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
14 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo
15 Completed Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study.
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Dietary Supplement: High oral Fructose challenge (150g per day for 28 days)
16 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Intervention: Other: Omega diet
17 Terminated
Has Results
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis (NASH);   Hepatic Steatosis
Interventions: Drug: Omega-3-acid ethyl esters (Lovaza);   Drug: Placebo
18 Completed Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Conditions: Hepatic Steatosis;   Fatty Liver
Intervention:
19 Completed Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic Steatohepatitis
Conditions: Non-Alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis;   Metabolic Syndrome
Interventions: Drug: Aramchol;   Drug: Placebo
20 Completed
Has Results
Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)
Conditions: Non-alcoholic Fatty Liver Disease;   Nonalcoholic Steatohepatitis
Intervention: Device: Tru-cut biopsy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years